CANGO INC/KY - ADR (CANG)
US1375861036 - ADR
Overall CANG gets a fundamental rating of 4 out of 10. We evaluated CANG against 122 industry peers in the Specialty Retail industry. No worries on liquidiy or solvency for CANG as it has an excellent financial health rating, but there are worries on the profitability. CANG is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
CANG had positive earnings in the past year.
In multiple years CANG reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: CANG reported negative operating cash flow in multiple years.
1.2 Ratios
Looking at the Return On Assets, with a value of -9.84%, CANG is doing worse than 73.55% of the companies in the same industry.
CANG's Return On Equity of -12.46% is in line compared to the rest of the industry. CANG outperforms 43.80% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.84% | ||
| ROE | -12.46% | ||
| ROIC | N/A |
ROA(3y)3.94%
ROA(5y)4.09%
ROE(3y)4.8%
ROE(5y)5.46%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
CANG has a Gross Margin of 8.55%. This is amonst the worse of the industry: CANG underperforms 95.04% of its industry peers.
CANG's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for CANG so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 8.55% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-46.74%
GM growth 5Y-29.95%
2. Health
2.1 Basic Checks
CANG does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CANG has about the same amount of shares outstanding.
The number of shares outstanding for CANG has been reduced compared to 5 years ago.
CANG has a better debt/assets ratio than last year.
2.2 Solvency
CANG has an Altman-Z score of 4.04. This indicates that CANG is financially healthy and has little risk of bankruptcy at the moment.
CANG has a better Altman-Z score (4.04) than 80.99% of its industry peers.
CANG has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.02, CANG is in the better half of the industry, outperforming 71.90% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 4.04 |
ROIC/WACCN/A
WACC8.63%
2.3 Liquidity
A Current Ratio of 4.13 indicates that CANG has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 4.13, CANG belongs to the top of the industry, outperforming 95.04% of the companies in the same industry.
A Quick Ratio of 4.13 indicates that CANG has no problem at all paying its short term obligations.
The Quick ratio of CANG (4.13) is better than 98.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.13 | ||
| Quick Ratio | 4.13 |
3. Growth
3.1 Past
CANG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -100.27%.
CANG shows a strong growth in Revenue. In the last year, the Revenue has grown by 91.08%.
The Revenue has been growing by 55.29% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-100.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.16%
Revenue 1Y (TTM)91.08%
Revenue growth 3Y53.17%
Revenue growth 5Y55.29%
Sales Q2Q%-88.51%
3.2 Future
The Earnings Per Share is expected to grow by 81.71% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 14.29% on average over the next years. This is quite good.
EPS Next Y-1100%
EPS Next 2Y-199.67%
EPS Next 3Y81.71%
EPS Next 5YN/A
Revenue Next Year-49.58%
Revenue Next 2Y-21.02%
Revenue Next 3Y14.29%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
CANG is valuated quite expensively with a Price/Earnings ratio of 114.29.
CANG's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 27.83. CANG is valued rather expensively when compared to this.
The Forward Price/Earnings Ratio is negative for CANG. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 114.29 | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as CANG's earnings are expected to grow with 81.71% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-199.67%
EPS Next 3Y81.71%
5. Dividend
5.1 Amount
CANG does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
CANGO INC/KY - ADR
NYSE:CANG (12/18/2024, 8:07:11 PM)
After market: 7.35 -0.65 (-8.13%)8
+1.09 (+15.77%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap834.92M
Analysts
Price Target
Short Float %
Short Ratio
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 114.29 | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.84% | ||
| ROE | -12.46% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 8.55% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.41
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 4.13 | ||
| Quick Ratio | 4.13 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-100.27%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-1100%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)91.08%
Revenue growth 3Y53.17%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y